Literature DB >> 7881843

Idiopathic juvenile osteoporosis: experience of twenty-one patients.

R Smith1.   

Abstract

The features and outcome of 21 children (12 boys, nine girls) with idopathic juvenile osteoporosis (IJO) followed for up to 23 yr are described. The mean age of onset was 7 yr (range 1-13 yr) with no sex difference; the main presenting symptoms were long bone fractures, pain in the back and difficulty in walking. Typically, radiographs demonstrated compression of the vertebrae and metaphyses of the long bones; bone histology sometimes showed an excess of osteocytes associated with woven bone; routine biochemistry was normal for age; and with three exceptions no abnormalities of extracted dermal collagen or collagen synthesized by fibroblasts were detected. Where circulating vitamin D metabolites were measured they were within the normal range; and hip and spine bone mineral density (measured by DXA) was strikingly low. Five patients are still growing and two are currently untraceable. Of the remaining 14 who are now adults, 11 have substantially or completely recovered and three are disabled. Since spontaneous recovery occurs it remains impossible to assess the many forms of treatment given.

Entities:  

Mesh:

Year:  1995        PMID: 7881843     DOI: 10.1093/rheumatology/34.1.68

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  18 in total

Review 1.  Biphosphonates.

Authors:  J Allgrove
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

2.  Intravenous pamidronate in juvenile osteoporosis.

Authors:  N J Shaw; C M Boivin; N J Crabtree
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

Review 3.  Diagnosis of Osteoporosis in Children and Adolescents.

Authors:  Christine M Laine; Tero Laine
Journal:  Eur Endocrinol       Date:  2013-08-23

4.  Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients.

Authors:  Giampiero I Baroncelli; Francesco Vierucci; Silvano Bertelloni; Paola Erba; Elisa Zampollo; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2013-04-03       Impact factor: 2.626

5.  Idiopathic juvenile osteoporosis--an analysis of the muscle-bone relationship.

Authors:  P Płudowski; M Lebiedowski; M Olszaniecka; J Marowska; H Matusik; R S Lorenc
Journal:  Osteoporos Int       Date:  2006-09-02       Impact factor: 4.507

Review 6.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

7.  Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis.

Authors:  Ralph Melchior; Bernard Zabel; Jürgen Spranger; Roland Schumacher
Journal:  Eur J Pediatr       Date:  2004-10-23       Impact factor: 3.183

8.  Primary osteoporosis in children.

Authors:  Lay Ong Tan; Soo Yen Lim; Rashida Farhad Vasanwala
Journal:  BMJ Case Rep       Date:  2017-09-01

Review 9.  Causes, mechanisms and management of paediatric osteoporosis.

Authors:  Outi Mäkitie
Journal:  Nat Rev Rheumatol       Date:  2013-04-16       Impact factor: 20.543

10.  Evidence of altered matrix composition in iliac crest biopsies from patients with idiopathic juvenile osteoporosis.

Authors:  Ignacio Garcia; Vincent Chiodo; Yan Ma; Adele Boskey
Journal:  Connect Tissue Res       Date:  2015-11-05       Impact factor: 3.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.